Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-09
DOI
10.3389/fimmu.2020.605231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bioprinting of in vitro tumor models for personalized cancer treatment: a review
- (2020) Shuangshuang Mao et al. Biofabrication
- The Tumor Microenvironment of DLBCL in the Computational Era
- (2020) Giuseppina Opinto et al. Frontiers in Oncology
- Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs
- (2019) Betul Gok Yavuz et al. Scientific Reports
- Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment
- (2019) Luke Bu et al. ONCOGENE
- 3D models in the new era of immune oncology: focus on T cells, CAF and ECM
- (2019) Francesca Di Modugno et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Impact of B cell/lymphoid stromal cell crosstalk in B-cell physiology and malignancy
- (2019) Claire Lamaison et al. IMMUNOLOGY LETTERS
- Organoid culture containing cancer cells and stromal cells reveals that podoplanin-positive cancer-associated fibroblasts enhance proliferation of lung cancer cells
- (2019) Hiroshi Nakamura et al. LUNG CANCER
- Reciprocal signaling and direct physical interactions between fibroblasts and breast cancer cells in a 3D environment
- (2019) Deborah J. Wessels et al. PLoS One
- Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology
- (2019) Saba Nayar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
- (2019) Tianyi Liu et al. Frontiers in Cell and Developmental Biology
- The prognostic value of tumor‐associated macrophages in Non‐Hodgkin's Lymphoma: A systematic review and meta‐analysis
- (2019) Xuanxuan Xu et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma
- (2019) Emilie Decaup et al. Frontiers in Immunology
- Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count
- (2019) Yan-Li Li et al. BMC CANCER
- Design of spherically structured 3D in vitro tumor models -Advances and prospects
- (2018) L.P. Ferreira et al. Acta Biomaterialia
- Ex vivo synthetic immune tissues with T cell signals for differentiating antigen-specific, high affinity germinal center B cells
- (2018) Alberto Purwada et al. BIOMATERIALS
- 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment
- (2018) Sofia P. Rebelo et al. BIOMATERIALS
- Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?
- (2018) Jessica Hoarau-Véchot et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deleting Malignant B Cells With Second-Generation Anti-CD20 Antibodies
- (2018) Josh Sopp et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
- (2018) Bjoern Chapuy et al. NATURE MEDICINE
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pyruvate secreted from patient-derived cancer-associated fibroblasts supports survival of primary lymphoma cells
- (2018) Akihiko Sakamoto et al. CANCER SCIENCE
- A three-dimensional ex vivo tri-culture model mimics cell-cell interactions between acute myeloid leukemia and the vascular niche
- (2017) Laura J. Bray et al. HAEMATOLOGICA
- Tumor-associated macrophages: from basic research to clinical application
- (2017) Li Yang et al. Journal of Hematology & Oncology
- 3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro
- (2017) Robert G. Mannino et al. LAB ON A CHIP
- Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance
- (2017) Kristen B. Long et al. MOLECULAR IMMUNOLOGY
- A three-dimensional ex vivo tri-culture model mimics cell-cell interactions between acute myeloid leukemia and the vascular niche
- (2017) Laura J. Bray et al. HAEMATOLOGICA
- Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model
- (2017) Janina Kuen et al. PLoS One
- Guidelines for the management of diffuse large B-cell lymphoma
- (2016) Sridhar Chaganti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies
- (2015) T. R. W. Tipton et al. BLOOD
- Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
- (2015) Ali Roghanian et al. CANCER CELL
- High-Throughput Screening of Surface Marker Expression on Undifferentiated and Differentiated Human Adipose-Derived Stromal Cells
- (2015) Graham G. Walmsley et al. TISSUE ENGINEERING PART A
- Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
- (2015) Biswanath Majumder et al. Nature Communications
- Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial
- (2014) S. Riihijarvi et al. HAEMATOLOGICA
- High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma
- (2014) Francesco Marchesi et al. HEMATOLOGICAL ONCOLOGY
- An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
- (2014) Soo Jeong Nam et al. LEUKEMIA & LYMPHOMA
- Cell Growth in Aggregates Determines Gene Expression, Proliferation, Survival, Chemoresistance, and Sensitivity to Immune Effectors in Follicular Lymphoma
- (2013) Pauline Gravelle et al. AMERICAN JOURNAL OF PATHOLOGY
- A novel three-dimensional stromal-based model forin vitrochemotherapy sensitivity testing of leukemia cells
- (2013) Omar S. Aljitawi et al. LEUKEMIA & LYMPHOMA
- Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model
- (2013) E Decaup et al. Blood Cancer Journal
- Lymphotoxin-β Receptor Signaling through NF-κB2-RelB Pathway Reprograms Adipocyte Precursors as Lymph Node Stromal Cells
- (2012) Cécile Bénézech et al. IMMUNITY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy
- (2011) S. H. Lim et al. BLOOD
- 3D tumour models: novel in vitro approaches to cancer studies
- (2011) Agata Nyga et al. Journal of Cell Communication and Signaling
- Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell Mixtures
- (2011) C. E. Caicedo-Carvajal et al. Journal of Tissue Engineering
- Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
- (2010) J. D. Shields et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now